1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Predictive Biomarkers Market Size Growth Rate by Type: 2018 VS 2022 VS 2030
1.2.2 Cancer
1.2.3 Neurological Disorder
1.2.4 Cardiovascular Disorder
1.2.5 Immunological Disorder
1.2.6 Others
1.3 Market by Application
1.3.1 Global Predictive Biomarkers Market Share by Application: 2018 VS 2022 VS 2030
1.3.2 Diagnostic Centers
1.3.3 Academic Research Institutes
1.3.4 CRO?S
1.3.5 Bio-Pharmaceutical Companies
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Predictive Biomarkers Market Perspective (2018-2030)
2.2 Predictive Biomarkers Growth Trends by Region
2.2.1 Predictive Biomarkers Market Size by Region: 2018 VS 2022 VS 2030
2.2.2 Predictive Biomarkers Historic Market Size by Region (2018-2023)
2.2.3 Predictive Biomarkers Forecasted Market Size by Region (2023-2030)
2.3 Predictive Biomarkers Market Dynamics
2.3.1 Predictive Biomarkers Industry Trends
2.3.2 Predictive Biomarkers Market Drivers
2.3.3 Predictive Biomarkers Market Challenges
2.3.4 Predictive Biomarkers Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Predictive Biomarkers Players by Revenue
3.1.1 Global Top Predictive Biomarkers Players by Revenue (2018-2023)
3.1.2 Global Predictive Biomarkers Revenue Market Share by Players (2018-2023)
3.2 Global Predictive Biomarkers Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Predictive Biomarkers Revenue
3.4 Global Predictive Biomarkers Market Concentration Ratio
3.4.1 Global Predictive Biomarkers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Predictive Biomarkers Revenue in 2022
3.5 Predictive Biomarkers Key Players Head office and Area Served
3.6 Key Players Predictive Biomarkers Product Solution and Service
3.7 Date of Enter into Predictive Biomarkers Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Predictive Biomarkers Breakdown Data by Type
4.1 Global Predictive Biomarkers Historic Market Size by Type (2018-2023)
4.2 Global Predictive Biomarkers Forecasted Market Size by Type (2023-2030)
5 Predictive Biomarkers Breakdown Data by Application
5.1 Global Predictive Biomarkers Historic Market Size by Application (2018-2023)
5.2 Global Predictive Biomarkers Forecasted Market Size by Application (2023-2030)
6 North America
6.1 North America Predictive Biomarkers Market Size (2018-2030)
6.2 North America Predictive Biomarkers Market Size by Country (2018-2023)
6.3 North America Predictive Biomarkers Market Size by Country (2023-2030)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Predictive Biomarkers Market Size (2018-2030)
7.2 Europe Predictive Biomarkers Market Size by Country (2018-2023)
7.3 Europe Predictive Biomarkers Market Size by Country (2023-2030)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Predictive Biomarkers Market Size (2018-2030)
8.2 Asia-Pacific Predictive Biomarkers Market Size by Country (2018-2023)
8.3 Asia-Pacific Predictive Biomarkers Market Size by Country (2023-2030)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Predictive Biomarkers Market Size (2018-2030)
9.2 Latin America Predictive Biomarkers Market Size by Country (2018-2023)
9.3 Latin America Predictive Biomarkers Market Size by Country (2023-2030)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Predictive Biomarkers Market Size (2018-2030)
10.2 Middle East & Africa Predictive Biomarkers Market Size by Country (2018-2023)
10.3 Middle East & Africa Predictive Biomarkers Market Size by Country (2023-2030)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 Siemens Healthcare
11.1.1 Siemens Healthcare Company Detail
11.1.2 Siemens Healthcare Business Overview
11.1.3 Siemens Healthcare Predictive Biomarkers Introduction
11.1.4 Siemens Healthcare Revenue in Predictive Biomarkers Business (2018-2023)
11.1.5 Siemens Healthcare Recent Development
11.2 Roche Diagnostic
11.2.1 Roche Diagnostic Company Detail
11.2.2 Roche Diagnostic Business Overview
11.2.3 Roche Diagnostic Predictive Biomarkers Introduction
11.2.4 Roche Diagnostic Revenue in Predictive Biomarkers Business (2018-2023)
11.2.5 Roche Diagnostic Recent Development
11.3 G.E. Healthcare
11.3.1 G.E. Healthcare Company Detail
11.3.2 G.E. Healthcare Business Overview
11.3.3 G.E. Healthcare Predictive Biomarkers Introduction
11.3.4 G.E. Healthcare Revenue in Predictive Biomarkers Business (2018-2023)
11.3.5 G.E. Healthcare Recent Development
11.4 Abbott Laboratories
11.4.1 Abbott Laboratories Company Detail
11.4.2 Abbott Laboratories Business Overview
11.4.3 Abbott Laboratories Predictive Biomarkers Introduction
11.4.4 Abbott Laboratories Revenue in Predictive Biomarkers Business (2018-2023)
11.4.5 Abbott Laboratories Recent Development
11.5 Qiagen
11.5.1 Qiagen Company Detail
11.5.2 Qiagen Business Overview
11.5.3 Qiagen Predictive Biomarkers Introduction
11.5.4 Qiagen Revenue in Predictive Biomarkers Business (2018-2023)
11.5.5 Qiagen Recent Development
11.6 Johnson and Johnson
11.6.1 Johnson and Johnson Company Detail
11.6.2 Johnson and Johnson Business Overview
11.6.3 Johnson and Johnson Predictive Biomarkers Introduction
11.6.4 Johnson and Johnson Revenue in Predictive Biomarkers Business (2018-2023)
11.6.5 Johnson and Johnson Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
